Science Explorer Back to mapMap
Discussion
Researcher · Marche Polytechnic University · Italy

Matteo Santoni

Matteo Santoni publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Renal cell carcinoma treatment, Cancer Immunotherapy and Biomarkers and Bladder and Urothelial Cancer Treatments.

ORCID 0000-0001-7340-6173 OpenAlex
World rank
#219,961
of 7,710,434 ranked researchers
Rank in Italy
#5,133
of 242,206
Works
619
Citations
15k
Citations per work
24.6
h-index
65
i10-index 320Top 1% in Pulmonary and Respiratory Medicine
Matteo Santoni

What does Matteo Santoni research?

Matteo Santoni's work is mostly in Medicine (62%), Biochemistry, Genetics and Molecular Biology (19%).

Health Sciences: 385 works · 62.2% of their workMedicine: 385 works · 62.2% of their workPulmonary and Respiratory Medicine: 167 works · 26.9% of their workOncology: 137 works · 22.1% of their workSurgery: 62 works · 10.0% of their workEpidemiology: 20 works · 3.2% of their workLife Sciences: 118 works · 19.0% of their workBiochemistry, Genetics and Molecular Biology: 118 works · 19.0% of their workMolecular Biology: 64 works · 10.4% of their workCancer Research: 53 works · 8.6% of their workEverything else: 116 works · 18.8% of their workTHEIR WORKMatteo Santoni619works
Life Sciences19%Health Sciences62%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine38562.2%
    1. Biochemistry, Genetics and Molecular Biology11819.0%
  3. Everything else11618.8%
  1. 1Pulmonary and Respiratory Medicine27% of their works
  2. 2Oncology22% of their works
  3. 3Molecular Biology10% of their works
  4. 4Surgery10% of their works
  5. 5Cancer Research9% of their works
  6. 6Epidemiology3% of their works

Research topics

Which keywords describe Matteo Santoni's research?

The keywords of their largest research topics: Immunotherapy, Molecular Characterization, Genetic Mutations, Tumor Microenvironment, Metastatic, Renal Cell Carcinoma, Immune Checkpoint Blockade and PD-1 and PD-L1.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 22 words, with their numbers
  1. Immunotherapy4824 topics
  2. Molecular Characterization3522 topics
  3. Genetic Mutations3312 topics
  4. Tumor Microenvironment2603 topics
  5. Metastatic2441 topic
  6. Renal Cell Carcinoma2441 topic
  7. Immune Checkpoint Blockade1651 topic
  8. PD-1 and PD-L11651 topic
  9. Chemotherapy1512 topics
  10. Neoadjuvant Therapy1512 topics
  11. Bladder Cancer1081 topic
  12. Urothelial Carcinoma1081 topic
  13. Cancer Genomics931 topic
  14. Mutational Signatures931 topic
  15. Androgen Receptor871 topic
  16. Prostate Cancer871 topic
  17. Kidney Organoids741 topic
  18. Nephrogenesis741 topic
  19. Cancer521 topic
  20. Ferroptosis521 topic
  21. Pancreatic Cancer431 topic
  22. Surgical Complications431 topic

Where does Matteo Santoni work?

Matteo Santoni's main affiliation in the publication record is Marche Polytechnic University, Italy.

How many publications and citations does Matteo Santoni have?

OpenAlex counts 619 works and 15,200 citations for Matteo Santoni, an h-index of 65, ranking #219,961 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Matteo Santoni. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.